particular paragraph, there is a clear mention of children with underlying pulmonary disease, cystic fibrosis, and compromise of any systems -- of immune systems are at high risk. there was another document just six days later that describes the recall of children and infants tylenol directed at the public, but there was no mention of any conditions a child might have like cystic fibrosis that would make them more vulnerable. it makes sense in case you have to go to the doctor to get your medicine, but the doctor would have a chance to convey the hazard to the patient, but this is an over-the-counter drug. apparently, they kept the public out of the loop. about this pattern -- we have a feeling the product was defective that kept it away from public knowledge. they hired phantom contractors who purchased the product but did not inform -- in fact, the contractors were told not to tell store personnel. inform the doctors, do not inform the public. what we have here, i think, is a pattern of concealment. one of the things i am concerned about, with all due respect, your presentation has all the